Cite
HARVARD Citation
Matsuoka, H. et al. (2022). Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol. BMJ open. 12 (2), p. . [Online].